Profit

Pharma, Infra, IT compelling: Chrys Capital

PUBLISHED ON: November 3, 2011 | Duration: 16 min, 34 sec

facebooktwitteremailkoo
loading..
Ashish Dhawan, Senior MD of Chrys Capital says the 15-20 per cent correction in markets has been fair. Infra companies have themselves to blame for getting into real estate and bidding aggressively for BOT projects. However, infra stocks are compelling from a 3-4 year perspective. Mr Dhawan is also bullish on domestic pharma market and IT stocks.
ALSO WATCH
Congress Spreading Doctored Videos To Create Confusion: IT Minister Ashwini Vaishnaw

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com